This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Morton M. Kligerman, MD

JAMA. 1975;231(13):1381-1384.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SURGERY is currently the method of choice in the management of operable adenocarcinoma of the rectum. Unfortunately, as pointed out by Gilbertsen,¹ five-year survival is less than 50% in patients in whom resection is possible. Only 30% of all patients with rectal cancer are longterm survivors. Morson et al² state that surgery alone has little more to offer in the treatment of rectal cancer.... and in spite of all attempts at earlier diagnosis, there has been no significant change in the incidence of the different stages of rectal cancer over the past 25 years.

According to Gilbertsen,¹ "by the time of diagnosis, most of these cancers have already spread beyond the intestine to adjacent lymph nodes, contiguous organs, or to more remote areas." He reports that among 125 patients who died of adenocarcinoma of the rectum after "curative" resections, approximately half died with local recurrence.

Rectal cancer, . . . [Full Text PDF of this Article]

Author Affiliations
From the Cancer Research and Treatment Center, University of New Mexico, Albuquerque.

Footnotes
Reprint requests to Cancer and Research Treatment Center, University of New Mexico, 900 Camino de Salud, Albuquerque, NM 87131 (Dr. Kligerman).

Edited by Philip Rubin, MD.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?